Skip to main content

Coronavirus Update: Johnson & Johnson Vaccine Trial Enters Phase 3, AstraZeneca U.S. Trial Still Halted

Publish date:
Video Duration:

According to Johns Hopkins, There are over 31.7 million cases of the virus worldwide, with over 973,000 deaths.

The U.S. has surpassed 6.9 million cases with 201,000 deaths.

Per the COVID-19 Tracking Project, there were 49,439 new cases reported Tuesday, which is higher than the 39,472 cases reported the day earlier. 769,854 new tests were reported. And 854 deaths were reported yesterday, which is higher than the 287 deaths reported the day prior.

Health and Human Services Secretary Alex Azar said that the U.S. trial of AstraZeneca remains on hold.

Johnson & Johnson said the single-shot dose, which will be tested on 60,000 trial participants, followed positive data from a phase 2 trial , which demonstrated that the "safety profile and immunogenicity after a single vaccination were supportive of further development."

The company also reiterated its aim of producing and supplying more than one billion doses of the vaccine -- should it be approved by regulators -- through the course of 2021, and aims to have a decision on the vaccine's effectiveness either later this year or in the first months of the next.

CEO Alex Gorsky said, “ "As COVID-19 continues to impact the daily lives of people around the world, our goal remains the same - leveraging the global reach and scientific innovation of our company to help bring an end to this pandemic...As the world's largest healthcare company, we are bringing to bear our best scientific minds, and rigorous standards of safety, in collaboration with regulators, to accelerate the fight against this pandemic."

The World Health Organization says that around 150 potential vaccines are currently under some form of study, with 34 active human trials taking place from Russian to Bahrain.

You can follow Katherine Ross on Twitter at @byKatherineRoss.

Read more from Katherine Ross here.

Latest Videos From TheStreet and Jim Cramer:

Related Videos